Anabolic therapy for osteoporosis: update on efficacy and safety

ABSTRACT Anabolic agents for the treatment of osteoporosis increase bone density, improve bone strength, and reduce fracture risk. They are distinguished from antiresorptive drugs by their property of increasing osteoblastic bone formation. Teriparatide and abaloparatide are parathyroid hormone rece...

Full description

Bibliographic Details

Published in:	Archives of Endocrinology and Metabolism
Main Authors:	Leonardo Bandeira, E. Michael Lewiecki
Format:	Article
Language:	English
Published:	Brazilian Society of Endocrinology and Metabolism 2022-12-01
Subjects:	Osteoporosis treatment teriparatide abaloparatide romosozumab
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2359-39972022000500707&tlng=en